177 related articles for article (PubMed ID: 15601754)
1. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin.
Banes AK; Shaw SM; Tawfik A; Patel BP; Ogbi S; Fulton D; Marrero MB
Am J Physiol Cell Physiol; 2005 Apr; 288(4):C805-12. PubMed ID: 15601754
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
3. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
Hinton JM; Hill P; Jeremy J; Garland C
J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
[TBL] [Abstract][Full Text] [Related]
4. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors.
Watts SW; Yang P; Banes AK; Baez M
J Cardiovasc Pharmacol; 2001 Oct; 38(4):539-51. PubMed ID: 11588524
[TBL] [Abstract][Full Text] [Related]
5. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway.
Madamanchi NR; Li S; Patterson C; Runge MS
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):321-6. PubMed ID: 11231909
[TBL] [Abstract][Full Text] [Related]
7. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
8. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059.
Watts SW
J Pharmacol Exp Ther; 1996 Dec; 279(3):1541-50. PubMed ID: 8968381
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Vasc Res; 2001; 38(4):341-9. PubMed ID: 11455205
[TBL] [Abstract][Full Text] [Related]
10. Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway.
Guillet-Deniau I; Burnol AF; Girard J
J Biol Chem; 1997 Jun; 272(23):14825-9. PubMed ID: 9169451
[TBL] [Abstract][Full Text] [Related]
11. Attenuated 5-hydroxytryptamine receptor-mediated responses in aortae from streptozotocin-induced diabetic rats.
James GM; Hodgson WC; Davis EA; Haynes JM
Br J Pharmacol; 1994 Jan; 111(1):370-6. PubMed ID: 8012721
[TBL] [Abstract][Full Text] [Related]
12. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway.
Madamanchi NR; Li S; Patterson C; Runge MS
J Biol Chem; 2001 Jun; 276(22):18915-24. PubMed ID: 11278437
[TBL] [Abstract][Full Text] [Related]
13. Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells.
Ito T; Ikeda U; Shimpo M; Yamamoto K; Shimada K
Circulation; 2000 Nov; 102(20):2522-7. PubMed ID: 11076827
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species.
Banes-Berceli AK; Ogobi S; Tawfik A; Patel B; Shirley A; Pollock DM; Fulton D; Marrero MB
Vascul Pharmacol; 2005 Nov; 43(5):310-9. PubMed ID: 16290054
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
Banes A; Florian JA; Watts SW
J Pharmacol Exp Ther; 1999 Dec; 291(3):1179-87. PubMed ID: 10565840
[TBL] [Abstract][Full Text] [Related]
16. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction.
Florian JA; Watts SW
J Pharmacol Exp Ther; 1998 Jan; 284(1):346-55. PubMed ID: 9435197
[TBL] [Abstract][Full Text] [Related]
17. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells.
Watanabe S; Mu W; Kahn A; Jing N; Li JH; Lan HY; Nakagawa T; Ohashi R; Johnson RJ
Am J Nephrol; 2004; 24(4):387-92. PubMed ID: 15256805
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
Amiri F; Shaw S; Wang X; Tang J; Waller JL; Eaton DC; Marrero MB
Kidney Int; 2002 May; 61(5):1605-16. PubMed ID: 11967010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
